| Literature DB >> 23321811 |
P M Thompson1, C G Bernardo, D A Cruz, N S Ketchum, J E Michalek.
Abstract
Investigators are interested in determining whether lifetime behavioral traits and specific mood states experienced close to death affect brain gene and protein expression as assessed in post-mortem human brains. Major obstacles to conducting this type of research are the uncertain reliability of the post-mortem psychiatric diagnoses and clinical information because of the retrospective nature of the information. In this study, we addressed the concordance of clinical information obtained through an informant compared with information obtained through a clinician interview of the subject. To test this, we measured both lifetime and within the week psychiatric symptoms of subjects (n=20) and an informant, their next-of-kin (n=20) who were asked identical questions. We found Diagnostic and Statistical Manual (DSM)-IV axis 1 diagnoses by Mini-International Neuropsychiatric Interview proportion of positive agreement for major depression was 0.97, bipolar disorder was 0.81, whereas proportion of negative agreement was 0.97 for schizophrenia. Symptom scale intra-class correlation coefficients and 95% confidence interval were: Bipolar Inventory of Signs and Symptoms=0.59 (0.23, 0.81), Brief Psychiatric Rating Scale=0.58 (0.19, 0.81), Hamilton Depression Rating Scale=0.44 (0.03, 0.72), Montgomery Asberg Depression Rating Scale=0.44 (0.03, 0.72), Young Mania Rating Scale=0.61 (0.30, 0.82), Barratt Impulsiveness Score=0.36 (-0.11, 0.70) and Childhood Trauma Questionnaire=0.48 (-0.15, 0.83). We show that DSM-IV diagnoses; lifetime impulsivity severity, childhood trauma score and symptom scores were significantly consistent between the subjects and their informants. These data suggest, with some limitations, that both retrospective and informant obtained information can provide useful clinical information in post-mortem research.Entities:
Mesh:
Year: 2013 PMID: 23321811 PMCID: PMC3566714 DOI: 10.1038/tp.2012.133
Source DB: PubMed Journal: Transl Psychiatry ISSN: 2158-3188 Impact factor: 6.222
Demographic information on subjects and NOK
| Anglo | 14 (70%) | 11 (55%) | 25 (62.5%) |
| Hispanic | 6 (30%) | 7 (35%) | 13 (32.5%) |
| Black | 0 (0) | 2 (10%) | 2 (5%) |
| Total | 20 | 20 | 40 |
| Female | 12 (60%) | 10 (50%) | 22 (55%) |
| Male | 8 (40%) | 10 (50%) | 18 (45%) |
| Total | 20 | 20 | 40 |
| Parent | 3 (15%) | ||
| Sibling | 3 (15%) | ||
| Spouse | 12 (60%) | ||
| Ex-husband | 1 (5%) | ||
| Caregiver | 1 (5%) | ||
| Total | 20 (100%) | ||
Abbreviation: NOK, next-of-kin.
Proportion of positive and negative agreement between subjects and NOK with 95% confidence interval using the MINI semistructured exam for DSM-IV diagnoses
| Major depression | NOK | Yes No | 19 1 | 0 0 | 0.97 (0.89, 1) | 0 |
| Bipolar disorder | NOK | Yes No | 13 5 | 1 1 | 0.81 (0.65, 0.92) | 0.25 (0.06, 0.59) |
| Schizophrenia | NOK | Yes No | 0 0 | 1 19 | 0 | 0.97 (0.89, 1) |
| Panic Disorder | NOK | Yes No | 2 2 | 0 16 | 0.67 (0.29, 0.92) | 0.94 (0.82, 0.99) |
| Panic disorder with agoraphobia | NOK | Yes No | 1 5 | 4 10 | 0.18 (0.04, 0.47) | 0.69 (0.51,0.83) |
| Generalized anxiety disorder | NOK | Yes No | 0 3 | 3 14 | 0 | 0.82 (0.67, 0.92) |
| OCD | NOK | Yes No | 0 0 | 1 19 | 0 | 0.97 (0.89, 1) |
| PTSD | NOK | Yes No | 0 2 | 1 17 | 0 | 0.92 (0.8, 0.98) |
| Alcohol use disorder | NOK | Yes No | 1 4 | 2 13 | 0.25 (0.06, 0.59) | 0.81 (0.65, 0.92) |
| Drug use disorder | NOK | Yes No | 2 1 | 0 17 | 0.8 (0.37, 0.98) | 0.97 (0.87, 1) |
| Adult ADHD | NOK | Yes No | 0 2 | 0 18 | 0 | 0.95 (0.84, 0.99) |
Abbreviations: ADHD, attention defect, hyperactivity disorder; CI, confidence interval; DSM, Diagnostic and Statistical Manual; MIMI, Mini-International Neuropsychiatric Interview; NOK, next-of-kin (informant), OCD, obsessive compulsive disorder; PTSD, post-traumatic stress disorder.
Intra-class correlation coefficients with 95% confidence intervals between the subject and NOK for BISS, BPRS, MADRS, Ham-D, YMRS, CTQ, BISS illness subscale and Barratt Impulsivity Scale
| | 20 | 20 | |
| Mean (s.d.) | 17.2 (12.5) | 12.1 (11.6) | 0.44 (0.03, 0.72) |
| Min, max | 0, 50 | 0, 47 | |
| | 20 | 20 | |
| Mean (s.d.) | 11.4 (9.4) | 9 (10.2) | 0.44 (0.03, 0.72) |
| Min, max | 0, 33 | 0, 45 | |
| | 20 | 20 | |
| Mean (s.d.) | 7.5 (7.3) | 6 (8.9) | 0.61 (0.26, 0.82) |
| Min, max | 0, 26 | 0, 40 | |
| | 19 | 19 | |
| Mean (s.d.) | 24.5 (8.7) | 24.8 (8.6) | 0.58 (0.19, 0.81) |
| Min, max | 9, 48 | 18, 56 | |
| | 14 | 11 | |
| Mean (s.d.) | 56.6 (18.2) | 48.7 (13.8) | 0.48 (−0.15, 0.83) |
| Min, max | 30, 102 | 21, 76 | |
| | 20 | 20 | |
| Mean (s.d.) | 33.8 (21.4) | 24.4 (23.9) | 0.59 (0.23, 0.81) |
| Min, max | 6, 87 | 2, 112 | |
| Mania | |||
| | 20 | 20 | |
| Mean (s.d.) | 8.7 (7.9) | 7 (8.7) | 0.66 (0.34,0.85) |
| Min, max | 0, 31 | 0, 39 | |
| Depression | |||
| | 20 | 20 | |
| Mean (s.d.) | 9.5 (7) | 7 (7.2) | 0.28 (−0.16, 0.62) |
| Min, max | 0, 26 | 0, 22 | |
| Irritability | |||
| | 20 | 20 | |
| Mean (s.d.) | 4.5 (3.9) | 3.5 (3.7) | 0.57 (0.2, 0.8) |
| Min, max | 0, 14 | 0, 15 | |
| Anxiety | |||
| | 20 | 20 | |
| Mean (s.d.) | 3 (3.1) | 2.1 (3.6) | 0.46 (0.05, 0.74) |
| Min, max | 0, 10 | 0, 15 | |
| | 18 | 19 | |
| Mean (s.d.) | 73.9 (15.7) | 76.2 (15.8) | 0.36 (−0.11, 0.70) |
| Min, max | 47, 96 | 43, 112 | |
Abbreviations: BISS, Bipolar Disorder Inventory of Symptoms Scale; BPRS, Brief Psychiatric Rating Scale; CTQ, Childhood Trauma Questionnaire; Ham-D, Hamilton Depression Rating Scale; MADRS- Montgomery Asberg Depression Rating Scale, NOK, next-of-kin (informant); YMRS, Young Mania Rating Scale.
Previously published reliability assessments for post-mortem diagnoses
| Comparison groups | Medical record diagnosis to post-mortem structured case review | Police reports of diagnoses to DEAD plus | ME diagnoses to DEAD plus | Medical record diagnoses to consensus post-mortem diagnoses | Psychological autopsy to last available psychiatric record | Case history (ME records and NOK interview) to toxicology results | Psychological autopsy to medical record | Subject to informant interviews | Subject to informant interview |
| Study instrument | Item group checklist for the schedules for clinical assessment in neuropsychiatry DIBS | DEAD for DSM-IV | DEAD for DSM-III-R | DEAD for DSM-III-R | SCID for DSM-IV | NIDA-PSAAQ, SCID for DSM-IV | SCID-P and SCID-II for DSM-III-R | SCID-I, SCID-II for DSM-IV | SCID-1 for DSM-III-R |
| Statistic | Kappa coefficient | % Agreement | Kappa coefficient | Kappa coefficient | Kappa coefficient | % Agreement | % Agreement | Kappa coefficient | Kappa coefficient |
| Schizophrenia | 0.61 | 69.6%, (Kappa between DSM-III-R and DSM-IV=0.57) | 0.59 | 0.74 | Combined | 100 | NA | ||
| Schizoaffective disorder | 0.35 | Combined other psychotic disorders, 0.40 | 0.94 | 67 | |||||
| Delusional disorder | 100 ( | ||||||||
| Major depression | 0.95 | Combined mood disorders,0.79 | 0.63 | 88 | Combined mood disorders (excluding dysthymia), 0.79 (includes adjustment disorders), 0.79 | 1 | |||
| Bipolar disorder | 0.70 | 0.58 | 50 | ||||||
| Anxiety disorders | 0.66 | ||||||||
| Cocaine dependence | 42 | ||||||||
| Cannabis dependence | 76 | Combined, substance disorder 100 ( | |||||||
| Phencyclidine | 20 | ||||||||
| Opioids | 44 | ||||||||
| Alcohol dependence or abuse | 0.77 | 100 | 1 | ||||||
| All axis 1 | 0.57 | Kappa=0.84 | 0.65 | ||||||
| All axis 2 | 0.32 | Kappa=0.65 | |||||||
Abbreviations: DIBS, Diagnostic Instrument for Brain Studies; DEAD, Diagnostic Evaluation After Death; DSM, Diagnostic and Statistical Manuel of Mental Disorders; ME, medical examiner; NA, not applicable; NIDA, PSAAQ-National Institute on Drug Abuse-Post-Mortem Substance Abuse Assessment Questionnaire; NOK, next-of-kin; SCID, Structured Clinical Interview for DSM-IV.